Citations

Mayo Clinic

Showing 10 of 108551 citations.

Initial Experience and Clinical Assessment of the Karl Storz FLEX-XC1 Single-Use Flexible Ureteroscope
Alamiri, Jamal, Qi, Robert , Hanna, Kevin F. , White, Lindsay A. , Ungerer, Garrett , Kemble, Jayson , Thompson, Carly A., Potretzke, Aaron M. , Koo, Kevin , Ungerer, Garrett N, Kemble, Jayson P

Urology Practice | March 25, 2024 | Volume: 11 | Issue: 3 | Pages: 462-468

10.1097/upj.0000000000000552 | PMID 38526412 Get It

Transfusion Support in Hematopoietic Stem Cell Transplantation: A Contemporary Narrative Review
Jacobs, Jeremy W. , Booth, Garrett S. , Savani, Bipin N. , Adkins, Brian David , Jacobs, Jeremy W , Savani, Bipin N , Booth, Garrett , Adkins, Brian D. , Stephens, Laura D.

Clinical Hematology International | March 25, 2024 | Volume: 6 | Issue: 1 | Pages: No page available

10.46989/001c.94135 | PMID 38817704 Get It

Hematopoietic stem cell transplantation (HSCT) is a cornerstone of modern medical practice, and can only be performed safely and effectively with appropriate transfusion medicine support. Patients undergoing HSCT often develop therapy-related cytopenia, necessitating differing blood product requirements in the pre-, peri-, and post-transplant periods. Moreover, ensuring optimal management for patients alloimmunized to human leukocyte antigens (HLA) and/or red blood cell (RBC) antigens, as well as for patients receiving ABO-incompatible transplants, requires close collaboration with transfusion medicine and blood bank professionals. Finally, as updated transfusion guidelines and novel blood product modifications emerge, the options available to the transplant practitioner continue to expand. Herein, we detail contemporary blood transfusion and transfusion medicine practices for patients undergoing HSCT.
Using Curiosity, in Good Faith, as a Marker of an Exceptional Clinician
Abdelwahab, Rewan , Abdelwahab, Rewan M

Academic Medicine | March 25, 2024 | Volume: 99 | Issue: 6 | Pages: e1-e2

10.1097/acm.0000000000005716 | PMID 38526952 Get It

The Trajectory of Revisional Bariatric Surgery: Open to Laparoscopic to Robotic
Jawhar, Noura , Sample, Jack W. , Salame, Marita , Marrero, Katie , Tomey, Daniel , Puvvadi, Suraj , Tomey, Daniel , Sample, Jack W , Ghanem, Omar M.

Journal of Clinical Medicine | March 25, 2024 | Volume: 13 | Issue: 7 | Pages: 1878

10.3390/jcm13071878 | PMID 38610643 Get It

Metabolic and bariatric surgery (MBS) is the most effective therapeutic intervention for patients with obesity, with sleeve gastrectomy (SG) being the most commonly performed primary MBS procedure. Long-term studies have demonstrated that 15–20% of patients require revisional bariatric surgery (RBS) due to weight-related issues or surgical complications. Despite the gold standard being laparoscopic revision, there are other available approaches such as open or robotic-assisted. An extensive literature review was performed for articles from their inception to February 2024. A descriptive review of MBS procedures (SG, Roux-en-Y gastric bypass (RYGB), single anastomosis duodeno-ileostomy (SADI) and biliopancreatic diversion-duodenal switch (BPD-DS)) was carried out to report and compare outcomes between primary and revisional bariatric surgery. A similar review was conducted to compare outcomes of revisional approaches (open, laparoscopic, robotic). RYGB remains the dominant RBS with a similar safety profile compared to revisional SADI and BPD-DS. In terms of the RBS surgical approach, all three options showed comparable short and long-term outcomes, with robotic RBS being associated with longer operative time and variable length of stay. Additional long-term studies are required to further validate our conclusions.
Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry
Ghoreifi, Alireza , Pohar, Kamal S. , Holzbeierlein, Jeffrey M., Kates, Max , Willard, Brian, Taylor, Jennifer M. , Kaimakliotis, Hristos Z. , Porten, Sima P. , Tyson, Mark D. , Lotan, Yair , Group, Blue Light Cystoscopy with Cysview Registry, Ghoreifi, Alireza , Lotan, Yair , Ladi‐Seyedian, Seyedeh‐Sanam , Konety, Badrinath R. , Taylor, John Arthur , Liao, Joseph C. , Steinberg, Gary D. , Daneshmand, Siamak , Group, Blue Light Cystoscopy with Cysview Registry

Cancers | March 25, 2024 | Volume: 16 | Issue: 7 | Pages: 1268

10.3390/cancers16071268 | PMID 38610946 Get It

The use of blue light cystoscopy (BLC) has been shown to improve bladder tumor detection. However, data demonstrating the efficacy of BLC across different races are limited. Herein, we aim to evaluate heterogeneity in the characteristics of BLC for the detection of malignant lesions among various races. Clinicopathologic information was collected from patients enrolled in the multi-institutional Cysview® registry (2014–2021) who underwent transurethral resection or biopsy of bladder tumors. Outcome variables included sensitivity and negative and positive predictive values of BLC and white light cystoscopy (WLC) for the detection of malignant lesions among various races. Overall, 2379 separate lesions/tumors were identified from 1292 patients, of whom 1095 (85%) were Caucasian, 96 (7%) were African American, 51 (4%) were Asian, and 50 (4%) were Hispanic. The sensitivity of BLC was higher than that of WLC in the total cohort, as well as in the Caucasian and Asian subgroups. The addition of BLC to WLC increased the detection rate by 10% for any malignant lesion in the total cohort, with the greatest increase in Asian patients (18%). Additionally, the positive predictive value of BLC was highest in Asian patients (94%), while Hispanic patients had the highest negative predictive value (86%). Our study showed that regardless of race, BLC increases the detection of bladder cancer when combined with WLC.
Outpatient surgery benchmarks and practice variation patterns: case controlled study
Zhang, Chi , Shariq, Omair A. , Bews, Katherine A. , Poruk, Katherine E. , Mrdutt, Mary M., Foster, Trenton R. , Etzioni, David A. , Poruk, Katherine, Mrdutt, Mary M , Habermann, Elizabeth B. , Thiels, Cornelius A.

International Journal of Surgery | March 25, 2024 | Volume: 110 | Issue: 10 | Pages: 6297-6305

10.1097/js9.0000000000001392 | PMID 38526509 Get It

Background: Despite numerous potential benefits of outpatient surgery, there is currently a lack of national benchmarking data available for hospitals and surgeons to compare their own outcomes as they transition toward outpatient surgery. Materials and methods: Patients who underwent 14 common general surgery operations from 2016 to 2020 were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. Operations were selected based on frequency and the ability to be performed both inpatient and outpatient. Postoperative complications and readmissions were compared between patients who underwent inpatient vs outpatient surgery. After adjusting for patient comorbidities, multivariable models assessed the effect of patient characteristics on the odds of experiencing postoperative complications. A separate multi-institutional study of 21 affiliated hospitals assessed practice variation. Results: In 13 of the 14 studied procedures, complications were lower for patients who were selected for outpatient surgery (all P<0.01); minimally invasive (MIS) adrenalectomy showed no difference (P=0.61). Multivariable analysis confirmed these findings; the odds of experiencing any adverse events were lower following outpatient surgery in all operations but MIS adrenalectomy (OR 0.97; 95% CI: 0.47–2.02). Analysis of institutional practices demonstrated variation in the rate of outpatient surgery in certain breast, endocrine, and hernia repair operations. Conclusions: Institutional practice patterns may explain the national variation in the rate of outpatient surgery. While the present data does not support the adoption of outpatient surgery to less optimal candidates, addressing unexplained practice variations could result in improved utilization of outpatient surgery.
The PUG Flap: Conjoined Profunda Artery Perforator and Upper Gracilis Flap for Breast Reconstruction
Abdulwadood, Isra , Jarvis, Nicholas R. , Winocour, Sebastian, Rebecca, Alanna M. , Casey, William J., Reece, Edward M., Pflibsen, Lacey R.

Plastic and Reconstructive Surgery - Global Open | March 25, 2024 | Volume: 12 | Issue: 3 | Pages: e5544

10.1097/gox.0000000000005544 | PMID 38528848 Get It

Summary: Abdominal-based free flaps are the mainstay of autologous breast reconstruction; however, the region may not be ideal for patients with inadequate soft tissue or history of abdominal surgery. This case describes the use of a novel conjoined flap based on the profunda artery perforator and upper gracilis pedicles, named the perforator and upper gracilis (PUG) flap. This flap design aims to maximize medial thigh flap volume while ensuring robust tissue perforation. Here, we present our experience with the PUG flap in a breast cancer patient undergoing autologous reconstruction. The patient was a 41-year-old woman seeking nipple-sparing mastectomy and immediate autologous reconstruction with the PUG flap due to limited abdominal tissue availability. The gracilis and profunda artery perforator flaps were elevated using one boomerang-style skin paddle. Once harvested, the flaps were inset with antegrade and retrograde flow off the internal mammary arteries and both respective internal mammary veins. The donor site was closed in a V-Y pattern resulting in a thigh lift–type lift and concealed scar. In conclusion, the boomerang-style PUG flap maximizes medial thigh free tissue transfer volume, offers internal blood flow redundancy, and maintains good cosmesis of the donor site.
Blood volume phenotypes and patient sex in resistant hypertension
Carry, Brendan, Miller, Wayne L.

Journal of Hypertension | March 25, 2024 | Volume: 42 | Issue: 5 | Pages: 917-921

10.1097/hjh.0000000000003688 | PMID 38526133 Get It

The relationship of blood volume (BV) to systemic blood pressure (BP) is not well defined in resistant hypertension (RH). The goal of this study was to examine the extent to which systemic BP stratified by patient sex would impact BV phenotypes. A retrospective analysis of clinical and quantitative BV data was undertaken in a cohort of ambulatory patients with a history of controlled and uncontrolled RH. We analyzed 253 unique BVs with 54% of patients above goal BP of <150 mmHg. BV phenotypes were highly variable but no correlation of systolic BP to absolute BV or percentage deviation from normal volume was identified in either sex. Males demonstrated overall larger absolute BVs with higher prevalence of large plasma volume (PV) expansion; females were overall more hypovolemic by total BV but with a higher frequency of normal PV than males. Females trended towards more RBC mass deficit (true anemia) (49% vs. 38%. P = 0.084) while more males demonstrated RBC mass excess (erythrocythemia) (21% vs. 11%, P = 0.029). Importantly, a significant portion (52%) of patients with true anemia identified by BVA would go undetected by hemoglobin measurement alone. BV phenotypes are highly diverse in patients with RH. However, absolute BV or variability in BV phenotypes even when stratified by patient sex did not demonstrate an association with systemic BP. BV phenotyping provides a key to optimizing clinical management by identifying RBC mass profiles particularly distinguishing true anemia, dilutional anemia, and erythrocythemia and the contribution of PV expansion. Findings support the clinical utility of BV phenotyping in RH.
Kidney Stones Account for Increased Imaging Studies in Autosomal Dominant Polycystic Kidney Disease
Simmons, Kathryn , Ullman, Lawrence S. , Dahl, Neera K. , Simmons, Kathryn E , Dahl, Neera K

Kidney360 | March 25, 2024 | Volume: 5 | Issue: 5 | Pages: 707-714

10.34067/kid.0000000000000424 | PMID 38526140 Get It

Key Points Kidney stones are common in patients with autosomal dominant polycystic kidney disease compared with matched controls with CKD. The increase in imaging seen in patients with autosomal dominant polycystic kidney disease correlates with the kidney stone burden in these patients. Background Patients with autosomal dominant polycystic kidney disease (ADPKD) may have more imaging studies than patients with other forms of CKD. We characterized the imaging burden of patients with ADPKD relative to a CKD population to determine which factors lead to increased imaging in patients with ADPKD. Methods We retrospectively reviewed patients seen at Yale Nephrology between January 2012 and January 2021. We collected demographic, clinical, and imaging data through automated query and manual chart review. Eight hundred seven patients with ADPKD were matched to 4035 CKD controls on the basis of criteria of sex, race, ethnicity, CKD stage, hypertension, and diabetes, but not age. The number of abdominal imaging studies were compared between ADPKD and CKD groups, and the effect of kidney stone diagnosis was further evaluated. Chi-square and t tests were used to evaluate demographic variables, and Kruskal Wallis and negative binomial regression models were used to evaluate differences between abdominal imaging studies. Results Patients with ADPKD had a greater number of total abdominal imaging studies ( P < 0.0001), ultrasounds ( P < 0.0001), and magnetic resonance imagings ( P = 0.02) compared with controls. In patients with preserved renal function (eGFR >60 ml/min per m 2 ), these differences persisted. Kidney stones were significantly more common among patients with ADPKD ( P < 0.0001). In multivariable assessment of imaging study counts using a negative binomial model controlling for kidney stones, ADPKD was no longer a significant predictor. In patients with ADPKD, pyelonephritis; cyst complications; lower eGFR; diabetes; coronary artery disease; kidney stones; lower body mass index; and being male, Black, and younger increased the likelihood of having more imaging studies. Conclusions The higher prevalence of abdominal imaging studies in patients with ADPKD correlated with the increased incidence of kidney stones observed in this population.
Unveiling the Hidden Consequences: Initial Impact of COVID-19 on Colorectal Cancer Operation
Violante, Tommaso , Day, Courtney N. , Mathis, Kellie L. , Dozois, Eric J. , Violante, Tommaso , Ferrari, Davide , McKenna, Nicholas P. , Larson, David W.

Journal of the American College of Surgeons | March 25, 2024 | Volume: 239 | Issue: 2 | Pages: 85-97

10.1097/xcs.0000000000001042 | PMID 38525960 Get It

BACKGROUND: The COVID-19 pandemic has severely affected healthcare systems globally, resulting in significant delays and challenges in various medical treatments, particularly in cancer care. This study aims to investigate the repercussions of the pandemic on surgical interventions for colorectal cancer (CRC) in the US, using data from the National Cancer Database. STUDY DESIGN: We conducted a retrospective analysis of the National Cancer Database, encompassing adult patients who underwent surgical procedures for colon and rectal cancer in 2019 (pre-COVID) and 2020 (COVID). We examined various demographic and clinical variables, including patient characteristics, tumor staging, surgical approaches, and socioeconomic factors. RESULTS: The analysis included 105,517 patients, revealing a 17.3% reduction in surgical cases during the initial year of the pandemic. Patients who underwent surgery in 2020 displayed more advanced clinical and pathological tumor stages compared to those treated in 2019. After diagnosis, no delay was reported in the treatment. Patients operated during the pandemic, Black patients, uninsured, and Medicaid beneficiaries had worse stage colon and rectal cancer, and individuals with lower incomes bore the burden of advanced colon cancer. CONCLUSIONS: The impact of the COVID-19 pandemic on CRC surgery transcends a mere decline in case numbers, resulting in a higher prevalence of patients with advanced disease. This study underscores the exacerbated disparities in cancer care, particularly affecting vulnerable populations. The COVID-19 pandemic has left a significant and enduring imprint on CRC surgery, intensifying the challenges faced by patients and healthcare systems. Comprehensive studies are imperative to comprehend the long-term consequences of delayed screenings, diagnoses, and treatments as healthcare planning for the future must consider the unintended repercussions of pandemic-related disruptions.